Multiple Sclerosis News Today Forums Forums Trials and Research Survey Highlights European MS Therapy Switches

  • Survey Highlights European MS Therapy Switches

    Posted by ms-news-today-moderator on September 4, 2019 at 10:37 am

    Novartis’ Gilenya, Sanofi Genzyme’s Aubagio, and Biogen’s Tysabri and Tecfidera dominate recent MS therapy switches in Europe, a Spherix survey found. Read the full story here.

    What do you think of this story? Does this surprise you?

    replied 4 years, 6 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.